Simply Wall St.
IQVIA Expands In Vitro Discovery Footprint As Shares Face Pressure
📊
AI Sentiment
Positive
6/10
- Home
- IQV
as of 03-12-2026 3:43pm EST
$164.77
$6.81
-3.97%
Iqvia is the result of the 2016 merger of Quintiles, a leading global contract research organization, and IMS Health, a leading healthcare data and analytics provider. The research and development segment focuses primarily on providing outsourced late-stage clinical trials for pharmaceutical, device, and diagnostic firms. The technology and analytics segment provides aggregated information and technology services to clients in the healthcare industry, including pharmaceutical companies, providers, payers, and policymakers, as well as data and analytics capabilities for clinical trials, including virtual trials. The company also has a small contract sales business.
| Founded: | 1982 | Country: | United States |
| Employees: | 93000 | City: | DURHAM |
| Market Cap: | 41.3B | IPO Year: | 2013 |
| Target Price: | $230.56 | AVG Volume (30 days): | 2.4M |
| Analyst Decision: | Strong Buy | Number of Analysts: | 16 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | annual |
| EPS: | 7.84 | EPS Growth: | 4.67 |
| 52 Week Low/High: | $134.65 - $247.04 | Next Earning Date: | 05-08-2026 |
| Revenue: | $9,739,000,000 | Revenue Growth: | 41.60% |
| Revenue Growth (this year): | 6.76% | Revenue Growth (next year): | 5.85% |
| P/E Ratio: | 20.74 | Index: | |
| Free Cash Flow: | 2.1B | FCF Growth: | -2.98% |
Stock Insider Trading Activity of IQVIA Holdings Inc. (IQV)
BOUSBIB ARI
Sell
See Remarks
IQV Dec 18, 2025
Avg Cost/Share
$222.43
Shares
36,564
Total Value
$8,132,930.52
Owned After
820,599
SEC Form 4
| Insider | Ticker | Relationship | Date | Transaction | Avg Cost | Shares | Total Value | Owned After | SEC Forms |
|---|---|---|---|---|---|---|---|---|---|
| BOUSBIB ARI | IQV | See Remarks | Dec 18, 2025 | Sell | $222.43 | 36,564 | $8,132,930.52 | 820,599 |
Earnings Transcripts
SEC 8-K filings with transcript text
2025 Q4 Q4 2025 Earnings
8-K BUY Feb 5, 2026 · 100% conf.
2025
Q4
Q4 2025 Earnings
8-K BUYFeb 5, 2026 · 100% conf.
AI Prediction BUY
1D
+1.73%
$184.08
Act: +3.61%
5D
+3.75%
$187.75
Act: -6.69%
20D
+5.63%
$191.15
Act: -3.23%
Price: $180.96 Prob +5D: 100% AUC: 1.000
0001628280-26-005605
iqv-202602050001478242FALSE00014782422026-02-052026-02-05
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): February 5, 2026
IQVIA HOLDINGS INC.
(Exact name of registrant as specified in its charter)
Delaware001-3590727-1341991 (State or other jurisdiction of incorporation)(Commission File Number)(IRS Employer Identification No.)
2400 Ellis Rd. Durham, North Carolina 27703 (Address of principal executive offices)
Registrant’s telephone number, including area code: (919) 998-2000
Not Applicable (Former name or former address, if changed since last report.)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act: Title of Each Class Trading Symbol Name of Each Exchange on which Registered Common Stock, par value $0.01 per share “IQV” New York Stock Exchange
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.☐
Item 2.02 Results of Operations and Financial Condition
On February 5, 2026, IQVIA Holdings Inc. (the “Company”) issued a press release announcing its financial results for the fourth-quarter and full-year ended December 31, 2025. The full text of the press release was posted on the Company’s internet website and is furnished as Exhibit 99.1 hereto and incorporated herein by reference.
Pursuant to General Instruction B.2 of Current Report on Form 8-K, the information contained in, or incorporated into, Item 2.02, including the press release attached as Exhibit 99.1, is being furnished and shall not be deemed “filed” for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference into any registration statement or other filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference to such filing.
Item 9.01 Financial Statements and Exhibits
Exhibit No. Description
99.1 Press release dated February 5, 2026
104 Cover Page Interactive Data File (embedded within the Inline XBRL document)
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Date: February 5, 2026
IQVIA HOLDINGS INC.
By: /s/ Ronald E. Bruehlman Ronald E. Bruehlman Executive Vice President and Chief Financial Officer
2025 Q3 Q3 2025 Earnings
8-K Oct 28, 2025
2025
Q3
Q3 2025 Earnings
8-KOct 28, 2025
0001628280-25-046554
iqv-202510280001478242FALSE00014782422025-10-282025-10-28
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): October 28, 2025
IQVIA HOLDINGS INC.
(Exact name of registrant as specified in its charter)
Delaware001-3590727-1341991 (State or other jurisdiction of incorporation)(Commission File Number)(IRS Employer Identification No.)
2400 Ellis Rd. Durham, North Carolina 27703 (Address of principal executive offices)
Registrant’s telephone number, including area code: (919) 998-2000
Not Applicable (Former name or former address, if changed since last report.)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act: Title of Each Class Trading Symbol Name of Each Exchange on which Registered Common Stock, par value $0.01 per share “IQV” New York Stock Exchange
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.☐
Item 2.02 Results of Operations and Financial Condition
On October 28, 2025, IQVIA Holdings Inc. (the “Company”) issued a press release announcing its financial results for the third quarter ended September 30, 2025. The full text of the press release was posted on the Company’s internet website and is furnished as Exhibit 99.1 hereto and incorporated herein by reference.
Pursuant to General Instruction B.2 of Current Report on Form 8-K, the information contained in, or incorporated into, Item 2.02, including the press release attached as Exhibit 99.1, is being furnished and shall not be deemed “filed” for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference into any registration statement or other filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference to such filing.
Item 9.01 Financial Statements and Exhibits
Exhibit No. Description
99.1 Press release dated October 28, 2025
104 Cover Page Interactive Data File (embedded within the Inline XBRL document)
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Date: October 28, 2025
IQVIA HOLDINGS INC.
By: /s/ Ronald E. Bruehlman Ronald E. Bruehlman Executive Vice President and Chief Financial Officer
2025 Q2 Q2 2025 Earnings
8-K Jul 22, 2025
2025
Q2
Q2 2025 Earnings
8-KJul 22, 2025
0001478242-25-000102
iqv-202507220001478242FALSE00014782422025-07-222025-07-22
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): July 22, 2025
IQVIA HOLDINGS INC.
(Exact name of registrant as specified in its charter)
Delaware001-3590727-1341991 (State or other jurisdiction of incorporation)(Commission File Number)(IRS Employer Identification No.)
2400 Ellis Rd. Durham, North Carolina 27703 (Address of principal executive offices)
Registrant’s telephone number, including area code: (919) 998-2000
Not Applicable (Former name or former address, if changed since last report.)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act: Title of Each Class Trading Symbol Name of Each Exchange on which Registered Common Stock, par value $0.01 per share “IQV” New York Stock Exchange
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.☐
Item 2.02 Results of Operations and Financial Condition
On July 22, 2025, IQVIA Holdings Inc. (the “Company”) issued a press release announcing its financial results for the second quarter ended June 30, 2025. The full text of the press release was posted on the Company’s internet website and is furnished as Exhibit 99.1 hereto and incorporated herein by reference.
Pursuant to General Instruction B.2 of Current Report on Form 8-K, the information contained in, or incorporated into, Item 2.02, including the press release attached as Exhibit 99.1, is being furnished and shall not be deemed “filed” for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference into any registration statement or other filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference to such filing.
Item 9.01 Financial Statements and Exhibits
Exhibit No. Description
99.1 Press release dated July 22, 2025
104 Cover Page Interactive Data File (embedded within the Inline XBRL document)
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Date: July 22, 2025
IQVIA HOLDINGS INC.
By: /s/ Ronald E. Bruehlman Ronald E. Bruehlman Executive Vice President and Chief Financial Officer
Latest IQVIA Holdings Inc. News
IQV Breaking Stock News: Dive into IQV Ticker-Specific Updates for Smart Investing
Insider Monkey
IQVIA Holdings Inc. (IQV) Advances Clinical Research and Data Capabilities to Drive Growth
📈
AI Sentiment
Highly Positive
9/10
The Fly
Netflix resumed, Starbucks downgraded: Wall Street's top analyst calls
📈
AI Sentiment
Highly Positive
8/10
MT Newswires
Baird Adjusts Price Target on IQVIA Holdings to $243 From $268
📈
AI Sentiment
Highly Positive
8/10
MT Newswires
TD Cowen Upgrades IQVIA Holdings to Buy From Hold, Raises Price Target to $213 From $174
📈
AI Sentiment
Highly Positive
8/10
MT Newswires
Argus Research Adjusts IQVIA Holdings PT to $215 From $230, Maintains Buy Rating
📊
AI Sentiment
Positive
7/10
Compare IQV vs Leading Stocks
See how IQV stacks up against similar companies in the market
Head-to-Head Comparisons
Share on Social Networks:
Tools & Resources
Enhance your trading experience with our free tools
Disclaimer
The information presented on this page, "IQV IQVIA Holdings Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.